Microglia is a Key Player in the Reduction of Stroke Damage Promoted by the New Antithrombotic Agent Ticagrelor
Open Access
- 19 March 2014
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 34 (6) , 979-988
Abstract
The ADP-responsive P2Y12 receptor is expressed on both platelets and microglia. Clinical data show that ticagrelor, a direct-acting, reversibly binding P2Y12-receptor antagonist, reduces total cardiovascular events, including stroke. In our present study, we investigated the expression of P2Y12 receptors and the effects of ticagrelor on brain injury in Sprague-Dawley rats subjected to a permanent middle cerebral artery occlusion (MCAo). Rats were treated per os with ticagrelor 3 mg/kg or vehicle at 10 minutes, 22, and 36 hours after MCAo and killed after 48 hours. Immunofluorescence analysis showed an ischemia-related modulation of the P2Y12 receptor, which is constitutively expressed in Iba1+ resting microglia. After MCAo, activated microglia was mainly concentrated around the lesion, with fewer cells present inside the ischemic core. Ticagrelor significantly attenuated the evolution of ischemic damage—evaluated by magnetic resonance imaging (MRI) at 2, 24, and 48 hours after MCAo—, the number of infiltrating cells expressing the microglia/monocyte marker ED-1, the cerebral expression of proinflammatory mediators (interleukin 1 (IL-1), monocyte chemoattractant protein 1 (MCP-1), nitric oxide synthase (iNOS)) and the associated neurologic impairment. In transgenic fluorescent reporter CX3CR1-green fluorescent protein (GFP) mice, 72 hours after MCAo, ticagrelor markedly reduced GFP+ microglia and both early and late infiltrating blood-borne cells. Finally, in primary cultured microglia, ticagrelor fully inhibited ADP-induced Chemotaxis ( P12-mediated microglia activation and Chemotaxis.Keywords
This publication has 26 references indexed in Scilit:
- Microglial P2Y12 Deficiency/Inhibition Protects against Brain IschemiaPLOS ONE, 2013
- Time Course, Distribution and Cell Types of Induction of Transforming Growth Factor Betas following Middle Cerebral Artery Occlusion in the Rat BrainPLOS ONE, 2012
- TicagrelorCardiology in Review, 2011
- The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injuryBrain, 2009
- Adenosine A2A receptor mediates microglial process retractionNature Neuroscience, 2009
- The Recently Identified P2Y-Like Receptor GPR17 Is a Sensor of Brain Damage and a New Target for Brain RepairPLOS ONE, 2008
- Treatment with LXR agonists after focal cerebral ischemia prevents brain damageFEBS Letters, 2008
- The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl‐leukotrienes receptorThe EMBO Journal, 2006
- International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to TherapyPharmacological Reviews, 2006
- A Comparison of the Early Development of Ischaemic Damage following Permanent Middle Cerebral Artery Occlusion in Rats as Assessed Using Magnetic Resonance Imaging and HistologyJournal of Cerebral Blood Flow & Metabolism, 1995